Product
SHR-1901
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant TumorsStatus: Active (not recruiting), Estimated PCD: 2024-06-30